Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) Gross Profit (2019 - 2023)

Avai Bio's Gross Profit history spans 4 years, with the latest figure at $1.0 for Q1 2023.

  • For Q1 2023, Gross Profit changed N/A year-over-year to $1.0; the TTM value through Mar 2023 reached -$315110.0, changed N/A, while the annual FY2023 figure was -$40453.0, 80.81% up from the prior year.
  • Gross Profit for Q1 2023 was $1.0 at Avai Bio, down from $6592.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $87392.0 in Q3 2020 and bottomed at -$346194.0 in Q4 2020.
  • The 4-year median for Gross Profit is $6296.0 (2019), against an average of -$49927.6.
  • The largest YoY upside for Gross Profit was 1310.52% in 2020 against a maximum downside of 1310.52% in 2020.
  • A 4-year view of Gross Profit shows it stood at $6000.0 in 2019, then crashed by 5869.9% to -$346194.0 in 2020, then soared by 101.9% to $6592.0 in 2022, then tumbled by 99.98% to $1.0 in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Gross Profit are $1.0 (Q1 2023), $6592.0 (Q3 2022), and $24491.0 (Q2 2022).